The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

trividiahealth.com

Stage

Acquired | Acquired

Valuation

$0000 

About Trividia Health

Trividia Health, fka Nipro Diagnostics, is a global health and wellness company and developer, manufacturer, and marketer of diabetes monitoring and management products. With products sold under TRUE and store brand labels, the company is the exclusive partner and supplier of affordable, high-quality blood glucose monitoring and health and wellness solutions for retail pharmacies, distributors, and mail service providers.

Trividia Health Headquarter Location

2400 N.W. 55th Court

Fort Lauderdale, Florida, 33309,

United States

954-677-9201

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Trividia Health

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Trividia Health is included in 4 Expert Collections, including Diabetes.

D

Diabetes

1,750 items

D

Digital Health

13,075 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

M

Medical Devices

3,088 items

Companies that have been granted at least 1 510(k) by the FDA since 2014. Companies tagged as #FDA510(K)

H

Health Monitoring & Diagnostics

701 items

Companies developing technology to facilitate near-patient and point-of-care (POC) in vitro diagnostic testing. Companies tagged as #NearPatient&POCTesting

Trividia Health Patents

Trividia Health has filed 29 patents.

The 3 most popular patent topics include:

  • Diabetes
  • Blood tests
  • Insulin therapies
patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/21/2019

5/10/2022

Error detection and correction, Diabetes, Blood tests, Insulin therapies, Coding theory

Grant

Application Date

10/21/2019

Grant Date

5/10/2022

Title

Related Topics

Error detection and correction, Diabetes, Blood tests, Insulin therapies, Coding theory

Status

Grant

Latest Trividia Health News

14:45 EDT Point-of-Care Glucose Testing Market Report 2022-2030: Featuring Key Players Abbott, Nova Biomedical, Trividia Health ...

Jun 29, 2022

News provided by Share this article Share this article The global point-of-care glucose testing market size is expected to reach USD 4.5 billion by 2030, growing at a CAGR of 4.1% over the forecast period. An increase in the demand for Point-of-Care Testing (POCT) has been witnessed in recent years. As compared to the conventional laboratory testing performed in central lab settings, glucose POCT aids in performing effective diagnosis at the patient's bedside. The easy and convenient operation of POCT has largely favored the growing usage of glucose meters across medical settings. The demand for performing bedside monitoring of blood sugar levels efficiently in a capillary blood sample and the need to ensure better management of carbohydrate metabolism have propelled the companies to launch innovative glucose meters in the market. Point-of-Care Glucose Testing Market Report Highlights Accu-Chek Inform II accounted for the largest revenue share in 2021 and is anticipated to maintain this trend throughout the forecast period. Bayer Contour blood glucose monitoring system is set to grow at a CAGR of 6.1% from 2022 to 2030. North America is the leading regional market due to the higher penetration of novel diagnostic techniques. Asia Pacific is estimated to register the fastest CAGR owing to the ever-increasing prevalence of diabetes and numerous untapped growth opportunities in diagnostics. Moreover, a robust network of local manufacturers has significantly contributed to the revenue generated in this region. Key Topics Covered: Chapter 2. Executive Summary 3.1. Market Lineage Outlook

  • Where is Trividia Health's headquarters?

    Trividia Health's headquarters is located at 2400 N.W. 55th Court, Fort Lauderdale.

  • What is Trividia Health's latest funding round?

    Trividia Health's latest funding round is Acquired.

  • Who are the investors of Trividia Health?

    Investors of Trividia Health include Sinocare.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.